Cytosine arabinoside in the treatment of congenital cytomegalic inclusion disease
- 1 March 1972
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 80 (3) , 488-495
- https://doi.org/10.1016/s0022-3476(72)80515-8
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Disseminated varicella in apatient with acute myelogenous leukemia: Treatment with cytosine arabinosideThe Journal of Pediatrics, 1971
- COMPARISON OF THE ANTICYTOMEGALOVIRUS ACTIVITY OF A GROUP OF PYRIMIDINE ANALOGS *Annals of the New York Academy of Sciences, 1970
- THE EFFECT OF IDOXURIDINE ON THE EXCRETION OF CYTOMEGALOVIRUS IN CONGENITAL INFECTIONAnnals of the New York Academy of Sciences, 1970
- Severe generalized primary herpes treated with cytarabine.BMJ, 1970
- Congenital Cytomegalic Inclusion DiseaseAmerican Journal of Diseases of Children, 1969
- Congenital cytomegalovirus infection treated with idoxuridine.BMJ, 1968
- Immune competence in congenital rubella: Lymphocyte transformation, delayed hypersensitivity, and response to vaccinationThe Journal of Pediatrics, 1968
- RUBELLA-VIRUS/LEUCOCYTE INTERACTION AND ITS ROLE IN THE PATHOGENESIS OF THE CONGENITAL RUBELLA SYNDROMEThe Lancet, 1968
- Cytomegalovirus syndrome in children with acute leukemia. Treatment with floxuridineJAMA, 1967
- Comparative studies of leukemic cells sensitive and resistant to cytosine arabinosideBiochemical Pharmacology, 1965